Riskpilot← Back to searchSign inGet full accessC-MEDICAL AS
ASActiveOrg 999609708Sørkedalsveien 10D, 0369 OsloMedical specialists activities · NACE 8622Est. 20130 employeeswww.osloortopedsenter.no
Revenue 2022
NOK 55K
-99% vs 2021
EBITDA margin
-529.3%
-118% vs 2021
Equity ratio
99.6%
Financial strength
Net profit 2022
NOK -239K
-119% vs 2021
| Revenue | NOK 55K | -99% |
| EBITDA | NOK -292K | -118% |
| Net profit | NOK -239K | -119% |
| Total assets | NOK 1,7M | -14% |
| Equity | NOK 1,7M | -12% |
| Employees | 0 | — |
Legal name
C-MEDICAL AS
Org number
999609708
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
29. januar 2013
Share capital
NOK 50 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Daglig leder alene eller styrets leder alene.
Company purpose
Utvikling, kjøp og salg samt utleie av medisinsk utstyr samt formidling av medisinsk vitenskap og kirurgi og konsulenttjenester innen helsesektoren samt det som står i naturlig forbindelse med dette.
Address
Sørkedalsveien 10D, 0369 Oslo
Website
www.osloortopedsenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 982 | 3 651 | 8 019 | 11 459 | 10 007 | 5 355 | 55 |
| Staff expenses | −0 | −0 | −0 | −7 | −0 | −667 | −1 381 | −992 | −540 | −0 |
| EBITDA | −6 | −24 | −501 | −810 | 440 | −223 | −1 012 | 144 | 1 662 | −292 |
| Depreciation & amort. | −0 | −0 | −0 | −1 | −7 | −139 | −139 | −139 | −138 | −132 |
| EBIT | −6 | −24 | −501 | −811 | 433 | −362 | −1 151 | 5 | 1 524 | −425 |
| Net financials | −0 | −0 | −1 | −23 | −5 | −62 | −7 | −2 | 100 | 118 |
| Profit before tax | −6 | −24 | −501 | −834 | 428 | −423 | −1 158 | 4 | 1 624 | −306 |
| Tax | −0 | −0 | −135 | −192 | 113 | −74 | −253 | 1 | 357 | −67 |
| Net profit | −6 | −24 | −366 | −642 | 315 | −350 | −905 | 2 | 1 267 | −239 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 13 | 14 | 3 074 | 3 074 | 3 115 | 3 487 | 3 142 | 3 541 | 2 020 | 1 727 |
| Equity | 12 | −12 | −378 | 1 630 | 1 945 | 1 595 | 690 | 693 | 1 960 | 1 721 |
| Long-term debt | 0 | 0 | 0 | 404 | 404 | 203 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 | 26 | 3 452 | 1 040 | 766 | 1 689 | 2 452 | 2 848 | 60 | 7 |
| Total debt | 1 | 26 | 3 452 | 1 444 | 1 170 | 1 892 | 2 452 | 2 848 | 60 | 7 |
EBITDA margin
-529.3%
This company
15.8%
Market median
-3450% vs market
20132022
Equity ratio
99.6%
This company
38.2%
Market median
+161% vs market
20132022
Return on equity
-13.9%
This company
18.4%
Market median
-176% vs market
20132022
Net profit margin
-432.4%
This company
8.1%
Market median
-5438% vs market
20132022
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20132022
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20132022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TH Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
ER Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
C-Medical As | Company | 100.0% | 100.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
C-Medical Group As
C-MEDICAL AS Board members of C-MEDICAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Haugen Skorpen | Chief Executive Officer | 0 companies |
| Eskild Rudolf Larsen | Chief Executive Officer | 0 companies |
| Patrik Bø Egeland | Chairman | 0 companies |
| Martin Sture Fagerlund | Board of Directors | 0 companies |
| Andreas Prøven Bogsrud | Board of Directors | 0 companies |
| Øyvind Bakke | Chairman | 0 companies |